Biomarkers of Contrast-Induced Nephropathy:: Which Ones are Clinically Important?

Interv Cardiol Clin. 2020 Jul;9(3):335-344. doi: 10.1016/j.iccl.2020.02.004. Epub 2020 May 12.

Abstract

Contrast-induced acute kidney injury (CI-AKI) is a common complication after intravascular injection of iodinated contrast media, and it is associated with a prolonged in-hospital stay and unfavorable outcome. CI-AKI occurs in 5% to 20% among hospitalized patients. Its diagnosis relies on the increase in serum creatinine levels, which is a late biomarker of kidney injury. Novel and early serum and urinary biomarkers have been identified to detect kidney damage before the expected serum creatinine increase.

Keywords: Acute kidney injury; Biomarker; Contrast media; Contrast nephropathy.

Publication types

  • Review

MeSH terms

  • Acetylglucosaminidase / urine
  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / metabolism*
  • Acute Kidney Injury / physiopathology
  • Adaptor Proteins, Signal Transducing / urine
  • Albuminuria / diagnosis
  • Biomarkers / blood*
  • Biomarkers / urine*
  • Contrast Media / administration & dosage
  • Contrast Media / adverse effects*
  • Creatinine / blood
  • Cystatin C / blood
  • Fatty Acid-Binding Proteins / urine
  • Female
  • Hepatitis A Virus Cellular Receptor 1 / metabolism
  • Humans
  • Interleukin-18 / urine
  • Length of Stay / statistics & numerical data*
  • Lipocalin-2 / urine
  • Male
  • Midkine / blood
  • Retinol-Binding Proteins / urine
  • beta 2-Microglobulin / blood
  • beta 2-Microglobulin / urine

Substances

  • Adaptor Proteins, Signal Transducing
  • Biomarkers
  • Contrast Media
  • Cystatin C
  • DKK3 protein, human
  • FABP1 protein, human
  • Fatty Acid-Binding Proteins
  • HAVCR1 protein, human
  • Hepatitis A Virus Cellular Receptor 1
  • Interleukin-18
  • Lipocalin-2
  • Retinol-Binding Proteins
  • beta 2-Microglobulin
  • Midkine
  • Creatinine
  • Acetylglucosaminidase